Long-Term Safety and Efficacy of Percutaneous ... | 合法醫療器材資訊網

Update soon · A New Left Atrial Appendage Occluder (Lifetech LAmbre™ Device​) for Stroke Prevention in Atrial Fibrillation. · Preclinical Evaluation of a New Left ... Read More

由 XF Feng 著作 · 2019 · 被引用 8 次 — Left atrial appendage (LAA) closure (LAAC) has emerged as an alternative therapeutic approach to medical therapy for stroke prevention in ... Read More

由 G Wang 著作 · 2020 — Taken together, we demonstrate that execution of LAAC with the LAmbre device has high procedural success and prevents AF-related stroke. Read More

由 M Ali 著作 · 2020 · 被引用 5 次 — Results: The literature search retrieved n = 10 publications, encompassing n = 403 NVAF patients treated with a LAmbre™ LAAC, with relevant ... Read More

由 M Ali 著作 · 2020 · 被引用 5 次 — The LAmbre™ has entered the LAAC scene with a convincing cumulative evidence. Based on the available published data, the LAmbre™ LAAC ... Read More

由 G Wang 著作 · 2020 — Left atrial appendage closure (LAAC) using the LAmbre device has been associated with prevention of stroke in patients with nonvalvular atrial ... Read More

由 G Wang 著作 — Background. Left atrial appendage closure (LAAC) using the LAmbre device has been associated with prevention of stroke in patients with nonvalvular atrial ... Read More

2020年12月21日 — Background. Left atrial appendage closure (LAAC) using the LAmbre device has been associated with prevention of stroke in patients with ... Read More

由 M Ali 著作 · 2020 · 被引用 5 次 — We sought to systematically review the available LAAC data on the novel occluder device LAmbre™. Methods. For this systematic review, a ... Read More